Pedro A. Regidor
Ismaning, BY 85737, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Omega-3 long chain fatty acids and their metabolites in pregnancy outcomes for the modulation of maternal inflammatory- associated causes of preterm delivery, chorioamnionitis and preeclampsia.
Journal: F1000Research
Published: December 18, 2024
A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg.
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Published: September 16, 2024
The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users' acceptability and newborn development.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: July 29, 2024
Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature.
Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Published: April 08, 2023
The drospirenone (DRSP)-only pill: clinical implications in the daily use.
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Published: February 01, 2023
Obesity and contraceptive use: impact on cardiovascular risk.
Journal: ESC heart failure
Published: October 19, 2021
Metabolic and laboratory effects of a progestin-only pill containing drospirenone 4 mg in comparison to desogestrel 75 µg: a double-blind, double-dummy, prospective, randomised study.
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Published: August 05, 2021
Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg).
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Published: January 17, 2018
Drospirenone as estrogen-free pill and hemostasis: coagulatory study results comparing a novel 4 mg formulation in a 24 + 4 cycle with desogestrel 75 μg per day.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: March 31, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026